Breastfeeding News and Research RSS Feed - Breastfeeding News and Research

Many women choose to breastfeed their babies due to the significant health benefits provided over infant formula for both baby and mother.

Breast milk contains all the nutrients a baby requires for the first six months of life. Following this period, solid foods can gradually be introduced. The World Health Organization recommends feeding babies exclusively on breast milk for the first six months of life and then continuing breastfeeding once the infant has started to eat solid food, until up to two years of age.

Antibodies present in the breast milk boost the baby’s immune system and decrease the likelihood of diarrhoea, vomiting, or chest and ear infections developing. Breast feeding is also thought to decrease the risk of obesity later in life and therefore reduces the likelihood of conditions such as type 2 diabetes developing. Breast milk is also easier to digest than commercial formula.

For the mother, breastfeeding lowers the risk for breast and ovarian cancer as well as expending up to 500 calories a day, saving money, and helping to build a strong bond with the baby.

Any amount of breastfeeding has positive effects and the longer a child is breastfed for, the longer the health benefits will last for both baby and mother.
Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

Phase 3 trial: NEXAVAR tablets fail to meet primary endpoint in HER2-negative breast cancer patients

Bayer HealthCare and Onyx Pharmaceuticals Inc., an Amgen subsidiary, today announced that an investigational Phase 3 trial of NEXAVAR (sorafenib) tablets in patients with advanced breast cancer did not meet its primary endpoint of improving progression-free survival (PFS). [More]
Severe pain during and post delivery linked to postpartum depression

Severe pain during and post delivery linked to postpartum depression

Controlling pain during childbirth and post delivery may reduce the risk of postpartum depression, writes Katherine Wisner, M.D., a Northwestern Medicine- perinatal psychiatrist, in a July 23 editorial in Anesthesia & Analgesia. [More]
EGPAF experts to deliver presentations at AIDS 2014

EGPAF experts to deliver presentations at AIDS 2014

Experts from the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) will give oral presentations, moderate conference events, and exhibit a variety of educational posters and abstracts related to ending AIDS in children. [More]
Mothers who plan to breastfeed but return to work full-time are less likely to meet breastfeeding goals

Mothers who plan to breastfeed but return to work full-time are less likely to meet breastfeeding goals

Breastfeeding is known to provide significant health benefits for both infants and their mothers. However, while many women intend to breastfeed despite returning to work, a new study finds that mothers who plan to breastfeed for at least three months but return to work full-time are less likely to meet their breastfeeding goals. [More]
FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL). [More]
New article investigates effects of triclosan on health and environment

New article investigates effects of triclosan on health and environment

Earlier this year, mounting concerns over the potential health effects of triclosan, a common antimicrobial ingredient, prompted Minnesota to ban the germ-killer from consumer soaps statewide starting in 2017. [More]
Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Henry Ford launches clinical trial for treatment of tinnitus caused by noise trauma

Henry Ford Health System has launched a clinical trial to investigate a new drug for the treatment of tinnitus, a chronic ringing of the head or ears that affects more than 600 million people worldwide. [More]
Polly Toynbee to lead debate on public health at Sheffield Hallam University

Polly Toynbee to lead debate on public health at Sheffield Hallam University

Renowned journalist and Guardian columnist, Polly Toynbee will lead a debate on the power of research on public health outcomes at Sheffield Hallam University on Friday. [More]
State highlights: Illinois Medicaid digital shift delayed; N.C. hospitals fight cuts; heroin in New England

State highlights: Illinois Medicaid digital shift delayed; N.C. hospitals fight cuts; heroin in New England

Alexian Brothers Health System is suspending its effort to launch a new Medicaid program, blaming the difficulty of connecting physicians using different electronic records systems. The Arlington Heights, Ill.-based health system was spearheading a so-called accountable care entity (ACE) to coordinate the care of about 46,000 patients on Medicaid, the state-federal health insurance program for the poor and disabled. The ACEs are a form of managed care, one of Gov. Pat Quinn's initiatives to focus on preventative treatment to keep patients healthy and reduce health care costs (Schorsch, 6/17). [More]
Steroid injections can provide pain relief for mom without affecting baby

Steroid injections can provide pain relief for mom without affecting baby

From weird cravings to swollen feet, pregnant women deal with a lot during those nine months Some women even suffer from hand pain when there are simple, baby-safe options to treat the symptoms. [More]
Research to assess breastfeeding knowledge and confidence of Canadian physicians

Research to assess breastfeeding knowledge and confidence of Canadian physicians

The results of a national research project to assess breastfeeding knowledge, confidence, beliefs, and attitudes of Canadian physicians are available today in the Journal of Human Lactation. [More]
Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV). [More]
Auxilium and Prasco introduce authorized generic version of Testim

Auxilium and Prasco introduce authorized generic version of Testim

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that it has partnered with Prasco, LLC ("Prasco") to introduce an Authorized Generic version of Testim® (testosterone gel). [More]
New article explores why women still lag behind career advancement

New article explores why women still lag behind career advancement

Women have accounted for half the students in U.S. medical schools for nearly two decades, but as professors, deans, and department chairs in medical schools their numbers still lag far behind those of men. [More]
State highlights: Mental health funding in Kansas; EHR problems claim CEO's job; 'litany of woes' at IHS

State highlights: Mental health funding in Kansas; EHR problems claim CEO's job; 'litany of woes' at IHS

A selection of health policy stories from Arkansas, Florida, Georgia, Kansas, Michigan, Montana, Ohio, and Wyoming. [More]
ALOXI injection receives FDA approval for prevention of nausea, vomiting associated with cancer chemotherapy

ALOXI injection receives FDA approval for prevention of nausea, vomiting associated with cancer chemotherapy

Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years. [More]
Studies show mobile phones can cause allergic contact dermatitis in both children and adults

Studies show mobile phones can cause allergic contact dermatitis in both children and adults

Studies have identified mobile phones and related devices as sources of metal sensitization and potential causes of allergic contact dermatitis (ACD). [More]
Two new studies aim to change HIV infections in children, maternal deaths due to HIV

Two new studies aim to change HIV infections in children, maternal deaths due to HIV

HIV has been transformed into a chronic, manageable disease for most people living with HIV in the United States, where mother-to-child transmission of HIV is now a rare occurrence. [More]
Orexo US partners with inVentiv Health to market Zubsolv sublingual tablets in the US

Orexo US partners with inVentiv Health to market Zubsolv sublingual tablets in the US

Orexo AB announces a new partnership between Orexo US, Inc. and inVentiv Health for the commercialization of Zubsolv in the US. [More]

Fluoridating water does not affect children's mental development and adult IQ

New research out of New Zealand's world-renowned Dunedin Multidisciplinary Study does not support claims that fluoridating water adversely affects children's mental development and adult IQ. [More]